Addion and university create Europe's first 3D-printed eye models

MINNETONKA, Minn. & REHOVOT, Israel - Addion GmbH, in collaboration with Eyecer.at GmbH, has implemented Stratasys Ltd.'s (NASDAQ:SSYS) Digital Anatomy Solution to develop Europe's first 3D-printed anatomical eye models for eyelid surgery training, according to a company press release.

The technology, now in use at the Anatomical Institute of the University of Innsbruck, allows surgeons and medical students to practice delicate procedures on models that replicate human eye anatomy with high precision. Using Stratasys' PolyJet 3D printing technology, the models reproduce intricate details of the eye and surrounding tissues, including skin, muscle, and fat layers.

The innovation enables simulation of rare or complex pathologies, providing training opportunities across various surgical scenarios without requiring cadavers or animal models.

"We can now simulate rare and complex pathologies in a way that is ethical, reproducible, and remarkably realistic," said Alexander Hechenberger, CEO and founder of Addion GmbH.

The models incorporate advanced features such as simulated blood flow within printed tissue, allowing surgeons to experience realistic visual and tactile challenges during training.

Erez Ben Zvi, VP Healthcare at Stratasys, noted that the technology "combines material science and medical insight to replicate the true behavior of human tissue."

The solution aims to help healthcare institutions reduce costs and logistical barriers while creating consistent training environments. The technology is currently used by hospitals, universities, and medical device manufacturers globally for training, patient education, device testing, and preoperative planning.

Stratasys will showcase these eyelid surgery models at Formnext, taking place November 18-21 in Frankfurt. Despite recent stock weakness, with shares down over 10% in the past week, analysts remain optimistic about Stratasys's future, forecasting profitability this year. InvestingPro offers additional insights through its comprehensive Pro Research Report, available for Stratasys and 1,400+ other US equities.

In other recent news, Stratasys Ltd. reported its third-quarter 2025 earnings, which fell short of analysts' expectations. The company posted earnings per share of $0.02, significantly below the anticipated $0.09, resulting in a negative surprise of 77.78%. Additionally, revenue reached $137 million, missing the forecasted $143.85 million by 4.76%. In a strategic move, Stratasys has expanded into the metal 3D printing sector by investing in Tritone Technologies. This investment grants Stratasys an initial minority stake, with potential for increased ownership in the future. Meanwhile, Cantor Fitzgerald maintained its Overweight rating on Stratasys and raised the stock price target from $13.00 to $13.50, despite ongoing macroeconomic challenges and tariff impacts on gross margins. These developments highlight the company's efforts to diversify its portfolio amid financial challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.